• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Outcome of Photoselective Vaporization of the Prostate with the GreenLight-XPS 180 Watt System Compared to Transurethral Resection of the Prostate.与经尿道前列腺切除术相比,使用绿激光XPS 180瓦系统进行前列腺光选择性汽化的结果。
J Clin Med. 2019 Jul 10;8(7):1004. doi: 10.3390/jcm8071004.
2
Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial.绿激光 120-W 前列腺选择性汽化术与单极经尿道前列腺切除术的比较:一项多中心随机对照试验。
Eur Urol. 2012 Jun;61(6):1165-73. doi: 10.1016/j.eururo.2012.01.052. Epub 2012 Feb 8.
3
Photoselective vaporization of the prostate with GreenLight 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis of randomized controlled trials.绿光120瓦激光选择性汽化前列腺与经尿道前列腺切除术治疗良性前列腺增生的比较:一项随机对照试验的系统评价与荟萃分析
Lasers Med Sci. 2016 Feb;31(2):235-40. doi: 10.1007/s10103-015-1843-1. Epub 2015 Dec 28.
4
Comparison of GreenLight 180-W XPS laser vaporization versus transurethral resection of the prostate: Outcomes of a single regional center.绿激光 180-W XPS 激光汽化术与经尿道前列腺切除术治疗前列腺增生的比较:单中心的结果。
Arch Ital Urol Androl. 2020 Oct 1;92(3). doi: 10.4081/aiua.2020.3.169.
5
980-Nm Diode Laser Vaporization versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: Randomized Controlled Study.980纳米二极管激光汽化术与经尿道前列腺切除术治疗良性前列腺增生症的随机对照研究
Urol J. 2015 Nov 14;12(5):2355-61.
6
Greenlight high-performance system (HPS) 120-W laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a meta-analysis of the published results of randomized controlled trials.绿光高性能系统(HPS)120瓦激光汽化术与经尿道前列腺切除术治疗良性前列腺增生:随机对照试验已发表结果的荟萃分析
Lasers Med Sci. 2016 Apr;31(3):485-95. doi: 10.1007/s10103-016-1895-x. Epub 2016 Feb 11.
7
GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.绿光 HPS 120-W 激光汽化术与经尿道前列腺切除术治疗良性前列腺增生引起的下尿路症状:一项 2 年随访的随机临床试验。
Eur Urol. 2011 Oct;60(4):734-9. doi: 10.1016/j.eururo.2011.05.043. Epub 2011 Jun 1.
8
A prospective, randomized comparative study of monopolar transurethral resection of the prostate versus photoselective vaporization of the prostate with GreenLight 120-W laser, in prostates less than 80 cc.一项针对体积小于80立方厘米的前列腺,对比经尿道单极前列腺切除术与120瓦绿激光前列腺选择性汽化术的前瞻性随机对照研究。
Ther Adv Urol. 2015 Feb;7(1):3-8. doi: 10.1177/1756287214556643.
9
The 80-W KTP GreenLight laser vaporization of the prostate versus transurethral resection of the prostate (TURP): adjusted analysis of 5-year results of a prospective non-randomized bi-center study.80瓦KTP绿激光前列腺汽化术与经尿道前列腺切除术(TURP):一项前瞻性非随机双中心研究5年结果的校正分析
Lasers Med Sci. 2015 Apr;30(3):1147-51. doi: 10.1007/s10103-015-1721-x. Epub 2015 Feb 20.
10
180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study.180-W XPS 绿激光汽化术与经尿道前列腺电切术治疗良性前列腺梗阻:一项欧洲多中心随机试验——GOLIATH 研究的 6 个月安全性和疗效结果。
Eur Urol. 2014 May;65(5):931-42. doi: 10.1016/j.eururo.2013.10.040. Epub 2013 Nov 11.

引用本文的文献

1
Efficacy and safety of photoselective vaporization of the prostate using the Greenlight XPS 180W laser and simple prostatectomy for high-volume prostate hypertrophy: a comparative analysis.使用绿激光XPS 180W激光进行前列腺光选择性汽化术与开放性前列腺切除术治疗大体积前列腺增生症的疗效及安全性:一项对比分析
Cent European J Urol. 2024;77(1):64-76. doi: 10.5173/ceju.2023.191. Epub 2024 Jan 13.
2
GreenLight Laser™ Photovaporization versus Transurethral Resection of the Prostate: A Systematic Review and Meta-Analysis.绿激光光汽化术与经尿道前列腺切除术:一项系统评价和荟萃分析
Res Rep Urol. 2021 May 20;13:263-271. doi: 10.2147/RRU.S277482. eCollection 2021.
3
Enhanced photothermal hemostasis using dual wavelengths in an leporine kidney model.在兔肾模型中使用双波长增强光热止血作用
Biomed Opt Express. 2019 Sep 16;10(10):5198-5206. doi: 10.1364/BOE.10.005198. eCollection 2019 Oct 1.

本文引用的文献

1
Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline.良性前列腺增生所致下尿路症状的外科治疗:AUA 指南。
J Urol. 2018 Sep;200(3):612-619. doi: 10.1016/j.juro.2018.05.048. Epub 2018 Jun 11.
2
Enucleation, Vaporization, and Resection: How To Choose the Best Surgical Treatment Option for a Patient with Male Lower Urinary Tract Symptoms.去势、汽化和切除术:如何为男性下尿路症状患者选择最佳的手术治疗方案。
Eur Urol Focus. 2018 Jan;4(1):8-10. doi: 10.1016/j.euf.2018.04.020. Epub 2018 May 10.
3
Perioperative Changes and Progress in Photoselective Vaporization of the Prostate with GreenLight XPS 180 W System: A Single Center Experience.采用绿激光XPS 180W系统进行前列腺光选择性汽化术的围手术期变化与进展:单中心经验
Urol Int. 2018;100(4):463-469. doi: 10.1159/000487958. Epub 2018 Apr 5.
4
Multicentre international experience of 532-nm laser photoselective vaporization with GreenLight XPS in men with very large prostates.532nm 激光光选择性汽化术联合 GreenLight XPS 在超大前列腺患者中的多中心国际经验。
BJU Int. 2018 Nov;122(5):873-878. doi: 10.1111/bju.14208. Epub 2018 Apr 23.
5
Standard vs. anatomical 180-W GreenLight laser photoselective vaporization of the prostate: a propensity score analysis.标准与解剖 180-W 绿激光前列腺光选择性汽化术:倾向评分分析。
World J Urol. 2018 Jan;36(1):91-97. doi: 10.1007/s00345-017-2106-5. Epub 2017 Nov 1.
6
Efficacy, Safety, and Durability of 532 nm Laser Photovaporization of the Prostate with GreenLight 180 W XPS in Men with Acute Urinary Retention.180W绿光XPS系统532nm激光前列腺汽化术治疗急性尿潴留男性患者的疗效、安全性及持久性
J Endourol. 2017 Nov;31(11):1189-1194. doi: 10.1089/end.2017.0488. Epub 2017 Sep 28.
7
180W-LBO GreenLight XPS laser vaporization for benign prostatic hyperplasia: our experience with current markers of surgical proficiency for durable and reproducible outcomes.180W-LBO绿光XPS激光汽化术治疗良性前列腺增生:我们对手术熟练度当前指标的经验,以实现持久且可重复的结果。
Can J Urol. 2017 Aug;24(4):8922-8931.
8
Vaporize, anatomically vaporize or enucleate the prostate? The flexible use of the GreenLight laser.汽化、解剖学汽化还是摘除前列腺?绿激光的灵活应用。
Int Urol Nephrol. 2017 Mar;49(3):405-411. doi: 10.1007/s11255-016-1494-6. Epub 2017 Jan 2.
9
Safety and Efficacy of GreenLight XPS Laser Vapoenucleation in Prostates Measuring Over 150 mL.绿光XPS激光汽化切除术治疗体积超过150毫升前列腺的安全性和有效性
J Endourol. 2016 Aug;30(8):906-12. doi: 10.1089/end.2016.0288. Epub 2016 Jun 16.
10
Laser Vaporization of the Prostate With the 180-W XPS-Greenlight Laser in Patients With Ongoing Platelet Aggregation Inhibition and Oral Anticoagulation.180瓦XPS绿激光对正在接受血小板聚集抑制和口服抗凝治疗的患者进行前列腺汽化术。
Urology. 2016 May;91:167-73. doi: 10.1016/j.urology.2016.01.021. Epub 2016 Jan 29.

与经尿道前列腺切除术相比,使用绿激光XPS 180瓦系统进行前列腺光选择性汽化的结果。

Outcome of Photoselective Vaporization of the Prostate with the GreenLight-XPS 180 Watt System Compared to Transurethral Resection of the Prostate.

作者信息

Reimann Maximilian, Fishman Nikita, Lichy Isabel, Wiemer Laura, Hofbauer Sebastian, Almedom Zenai, Buckendahl John, Steiner Ursula, Schlomm Thorsten, Friedersdorff Frank, Cash Hannes

机构信息

Department of Urology, Charité-University Medicine Berlin, 12203 Berlin, Germany.

出版信息

J Clin Med. 2019 Jul 10;8(7):1004. doi: 10.3390/jcm8071004.

DOI:10.3390/jcm8071004
PMID:31295846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6678790/
Abstract

The aim of this paper was to compare the perioperative and postoperative results of photoselective vaporization of the prostate with the GreenLight-XPS 180 Watt System (PVP) and transurethral resection of the prostate (TURP). This retrospective study included 140 men who underwent PVP and 114 men who underwent TURP for symptomatic benign prostate enlargement (BPE) between June 2010 and February 2015. The primary outcome measures were the patient reported outcome, operative results, International Prostate Symptom Score-Quality of Life (IPSS-QoL), complication rates, catheterization time, and length of hospital stay. The median follow-up times were 27 months (range 14-44) for the PVP group and 36 months (range 25-47) for the TURP group. The patient characteristics were well balanced in both groups with a median age of 71 years (PVP group) vs. 70 years (TURP group) and a comparable prostate volume (median 50 mL in the PVP group vs. 45 mL in the TURP group). The IPSS-QoL was significantly higher in the PVP group than in the TURP group (median 22 + 4; range 16-27 + 3-5 vs. median 19 + 3; range 15-23 + 3-4; = 0.02). Men undergoing PVP were more likely to be on anticoagulants (PVP group = 23; 16% vs. TURP group = 2; 2%, < 0.001). The median operation time (OT; min) for both procedures was comparable with 68 min (PVP group; range 53-91) vs. 67 min (TURP group; range 46-85). The rate of severe intraoperative bleeding was significantly lower in the PVP group than in the TURP group ( = 7; 5% vs. = 16; 14%; = 0.01). The postoperative catheterization time and length of hospital stay was significantly lower in the PVP group (median 1-2 days; range 1-4) vs. the TURP group (median 2-4 days; range 2-5; both < 0.001). Complication rates (Clavien-Dindo classification ≥III) based on the follow-up data showed no statistically significant difference between the PVP group and the TURP group ( = 6; 4% vs. = 6; 5%; = 0.28). The IPSS on follow-up showed an equivalent reduction in symptoms for both treatment modalities (IPSS-QoL of 5 + 1; range 2-11 + 0-2 for both). There were no differences concerning urge (PVP group = 3; 2% vs. TURP group = 3; 3%; = 0.90) and men were similarly satisfied with the postoperative outcome (PVP group 92% vs. TURP group 87%; = 0.43). The PVP group was associated with a shorter hospitalization time and showed a reduced risk of bleeding, despite patients remaining on anticoagulants, without increasing the overall operative time. There was no difference in the patient reported outcome for both procedures.

摘要

本文旨在比较使用绿激光 XPS 180 瓦系统进行前列腺光选择性汽化术(PVP)与经尿道前列腺切除术(TURP)的围手术期和术后结果。这项回顾性研究纳入了 2010 年 6 月至 2015 年 2 月期间因症状性良性前列腺增生(BPE)接受 PVP 的 140 名男性和接受 TURP 的 114 名男性。主要观察指标包括患者报告的结果、手术结果、国际前列腺症状评分-生活质量(IPSS-QoL)、并发症发生率、导尿时间和住院时间。PVP 组的中位随访时间为 27 个月(范围 14 - 44 个月),TURP 组为 36 个月(范围 25 - 47 个月)。两组患者特征均衡,PVP 组中位年龄 71 岁,TURP 组中位年龄 70 岁,前列腺体积相当(PVP 组中位 50 mL,TURP 组中位 45 mL)。PVP 组的 IPSS-QoL 显著高于 TURP 组(中位数 22 + 4;范围 16 - 27 + 3 - 5 对比中位数 19 + 3;范围 15 - 23 + 3 - 4;P = 0.02)。接受 PVP 的男性更可能正在使用抗凝剂(PVP 组 n = 23;16% 对比 TURP 组 n = 2;2%,P < 0.001)。两种手术的中位手术时间(OT;分钟)相当,PVP 组为 68 分钟(范围 53 - 91 分钟),TURP 组为 67 分钟(范围 46 - 85 分钟)。PVP 组严重术中出血率显著低于 TURP 组(n = 7;5% 对比 n = 16;14%;P = 0.01)。PVP 组术后导尿时间和住院时间显著短于 TURP 组(中位数 1 - 2 天;范围 1 - 4 天)对比 TURP 组(中位数 2 - 4 天;范围 2 - 5 天;两者 P < 0.001)。基于随访数据的并发症发生率(Clavien-Dindo 分级≥III)在 PVP 组和 TURP 组之间无统计学显著差异(n = 6;4% 对比 n = 6;5%;P = 0.28)。随访时的 IPSS 显示两种治疗方式症状减轻程度相当(IPSS-QoL 均为 5 + 1;范围 2 - 11 + 0 - 2)。急迫性方面无差异(PVP 组 n = 3;2% 对比 TURP 组 n = 3;3%;P = 0.90),患者对术后结果的满意度相似(PVP组 92% 对比 TURP 组 87%;P = 0.43)。PVP 组住院时间较短,出血风险降低,尽管患者继续使用抗凝剂,但未增加总体手术时间。两种手术患者报告的结果无差异。